Results 141 to 150 of about 78,818 (344)
AAPM MEDICAL PHYSICS PRACTICE GUIDELINE 10.b: Scope of practice for clinical medical physics
Journal of Applied Clinical Medical Physics, Volume 26, Issue 11, November 2025.Abstract The American Association of Physicists in Medicine (AAPM) is a nonprofit professional society whose mission is “Advancing medicine through excellence in the science, education and professional practice of medical physics.” The AAPM has roughly 10,000 members and is the principal organization of medical physicists in the United States. The AAPM
Seng Boh Lim +8 more
wiley +1 more source
Atom Indonesia, 2012 Radioisotope 64Cu is a promising radiometallic-isotope for molecular-targeted-radiopharmaceuticals. Having a half-life of 12.70 hours and emitting β+-radiation (E+ = 0.6531 MeV) as well as β—ray (E = 0.5787 MeV), it is widely used in the form of ...
S. Soenarjo +5 more
doaj
Applications of the Strategic Defense Initiative's compact accelerators [PDF]
The Strategic Defense Initiative's (SDI) investment in particle accelerator technology for its directed energy weapons program has produced breakthroughs in the size and power of new accelerators.
Lynch, Ted, Montanarelli, Nick
core +1 more source
Focal Spot, Fall/Winter 1993 [PDF]
, 1993 https://digitalcommons.wustl.edu/focal_spot_archives/1065/thumbnail ...
core +1 more source
The Impact of Emerging Bioconjugation Chemistries on Radiopharmaceuticals
Journal of Nuclear Medicine, 2019 The use of radiolabeled antibodies, immunoglobulin fragments, and other proteins are an increasingly important sector of research for diagnostic imaging and targeted radiotherapy in nuclear medicine.
Rachael Fay, J. Holland
semanticscholar +1 more source
Hemodialysis‐associated radioactive waste management in [131I]I and [177Lu]Lu radionuclide therapy
Journal of Applied Clinical Medical Physics, Volume 26, Issue 11, November 2025.Abstract Background Radionuclide therapy, such as with iodine‐131 or lutetium‐177–labeled substances, is used to treat thyroid cancer and neuroendocrine tumors. Due to the incorporated radioactivity, patients must remain hospitalized until radiation levels are deemed safe, according to national regulations. This is particularly problematic for patients
Dennis Kupitz +4 more
wiley +1 more source
Radiopharmaceutical small-scale preparation in Europe: will we be able to harmonize the situation?
EJNMMI Radiopharmacy and ChemistryBackground Radiopharmaceuticals have been considered a special group of medicines in Europe since 1989. The use of radiopharmaceuticals that have marketing authorization should always be the first option in clinical use, however due to their special ...
Estrella Moya +3 more
doaj +1 more source
Strategies for Innovative Development of Tumor-targeted Theranostic Radiopharmaceuticals
Yuanzineng kexue jishuRadiopharmaceutical is an essential component of nuclear medicine and have demonstrated significant potential in disease diagnosis and treatment. In recent years, several tumor-targeted theranostic radiopharmaceuticals have been approved for market ...
HUANG Xuhu1, 2, 3, CHEN Huan1, 2, 3, LI Kexin1, 2, 3, WANG Ning1, 2, 3, ZHUANG Jin1, 2, 3, LI Hongyu1, 2, 3, DU Jin2, 3, 4
doaj +1 more source
Comparison of Tumor Uptake and Kinetics of Different Radiopharmaceuticals Under Experimental Conditions [PDF]
, 1972 D. Emrich +3 more
openalex +1 more source
Generating MRI‐Derived CSF Proxy‐Markers to Predict and Visualize Alzheimer's Disease Progression
Human Brain Mapping, Volume 46, Issue 16, November 2025.Deep learning models trained on structural MRI to predict cerebrospinal fluid‐based amyloid and tau concentrations can generate latent representations (MRI‐derived CSF proxy/surrogate markers) that can be subsequently transferred for Alzheimer's disease detection and risk prediction, bypassing noninvasive testing and enabling regional distribution ...
Anees Abrol +2 more
wiley +1 more source